Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ISONIAZID' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 386 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Collins, DM
      Virulence factors of Mycobacterium bovis

      TUBERCULOSIS
    2. Somoskovi, A; Parsons, LM; Salfinger, M
      The molecular basis of resistance to isoniazid, rifampin, and pyrazinamidein Mycobacterium tuberculosis

      RESPIRATORY RESEARCH
    3. Nguyen, M; Claparols, C; Bernadou, J; Meunier, B
      A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid - NAD(H) adducts

      CHEMBIOCHEM
    4. Mehrotra, J; Bishai, WR
      Regulation of virulence genes in Mycobacterium tuberculosis

      INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    5. Gennaro, MC; Calvino, R; Abrigo, C
      Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids

      JOURNAL OF CHROMATOGRAPHY B
    6. Nguyen, M; Quemard, A; Marrakchi, H; Bernadou, J; Meunier, B
      The nonenzymatic activation of isoniazid by Mn-III-pyrophosphate in the presence of NADH produces the inhibition of the enoyl-ACP reductase InhA fromMycobacterium tuberculosis

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE
    7. Zhang, Z; Chouchane, S; Magliozzo, RS; Rusling, JF
      Reversible electrochemistry and catalysis with Mycobacterium tuberculosis catalase-peroxidase in lipid films

      CHEMICAL COMMUNICATIONS
    8. Domenech, P; Honore, N; Heym, B; Cole, ST
      Role of OxyS of Mycobacterium tuberculosis in oxidative stress: overexpression confers increased sensitivity to organic hydroperoxides

      MICROBES AND INFECTION
    9. Burman, WJ; Reves, RR
      Hepatotoxicity from rifampin plus pyrazinamide - Lessons for policymakers and messages for care providers

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    10. Seifart, HI; Parkin, DP; Botha, FJH; Donald, PR; Van der Walt, BJ
      Population screening for isoniazid acetylator phenotype

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    11. van Loenhout-Rooyackers, JH; Keyser, A; Laheij, RJF; Verbeek, ALM; van der Meer, JWM
      Tuberculous meningitis: is a 6-month treatment regimen sufficient?

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    12. Martin, V; Guerra, JM; Cayla, JA; Rodriguez, JC; Blanco, MD; Alcoba, M
      Incidence of tuberculosis and the importance of treatment of latent tuberculosis infection in a Spanish prison population

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    13. Dye, C; Espinal, MA
      Will tuberculosis become resistant to all antibiotics?

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    14. Zahrt, TC; Song, JA; Siple, J; Deretic, V
      Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG

      MOLECULAR MICROBIOLOGY
    15. Dutt, M; Khuller, GK
      Liposomes and PLG microparticles as sustained release antitubercular drug carriers - an in vitro-in vivo study

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    16. Gillespie, SH
      Antibiotic resistance in the absence of selective pressure

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    17. Dutt, M; Khuller, GK
      Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    18. Kita, T; Tanigawara, Y; Chikazawa, S; Hatanaka, H; Sakaeda, T; Komada, F; Iwakawa, S; Okumura, K
      N-acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    19. Antonucci, G; Girardi, E; Raviglione, M; Vanacore, P; Angarano, G; Chirianni, A; Pagano, G; Suter, F; Lauria, FN; Ippolito, G
      Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study

      EUROPEAN RESPIRATORY JOURNAL
    20. Sharma, R; Saxena, D; Dwivedi, AK; Misra, A
      Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis

      PHARMACEUTICAL RESEARCH
    21. Zheng, XW; Yang, M; Zhang, ZJ
      The investigation of chemiluminescence reaction characteristic of the in situ electrogenerated Br-2 and its analytical application for isoniazid

      ACTA CHIMICA SINICA
    22. Singh, S; Mariappan, TT; Sankar, R; Sarda, N; Singh, B
      A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    23. Shishoo, CJ; Shah, SA; Rathod, IS; Savale, SS; Vora, MJ
      Impaired bioavailability of rifampicin in presence of isoniazid from fixeddose combination (FDC) formulation

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    24. Hotter, GS; Wilson, T; Collins, DM
      Identification of a cadmium-induced gene in Mycobacterium bovis and Mycobacterium tuberculosis

      FEMS MICROBIOLOGY LETTERS
    25. Silva, M; Lara, AS; Leite, CQF; Ferreira, EI
      Potential tuberculostatic agents: Micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid

      ARCHIV DER PHARMAZIE
    26. Luna, JAC
      Origin, present and future of resistance in tuberculosis

      ARCHIVOS DE BRONCONEUMOLOGIA
    27. Quigley, MA; Mwinga, A; Hosp, M; Lisse, I; Fuchs, D; Porter, JDH; Godfrey-Faussett, P
      Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

      AIDS
    28. de Pinho, AMF; Santoro-Lopes, G; Harrison, LH; Schechter, M
      Chemoprophylaxis for tuberculosis and survival of HIV infected patients inBrazil

      AIDS
    29. Johnson, JL; Okwera, A; Hom, DL; Mayanja, H; Kityo, CM; Nsubuga, P; Nakibali, JG; Loughlin, AM; Yun, H; Mugyenyi, PN; Vernon, A; Mugerwa, RD; Ellner, JJ; Whalen, CC
      Duration of efficacy of treatment of latent tuberculosis infection in HIV infected adults

      AIDS
    30. Piyaworawong, S; Yanai, H; Nedsuwan, S; Akarasewi, P; Moolphate, S; Sawanpanyalert, P
      Tuberculosis preventative therapy as part of a care package for people living with HIV in a district of Thailand

      AIDS
    31. Chauhan, R; Mande, SC
      Characterization of the Mycobacterium tuberculosis H37Rv alkyl hydroperoxidase AhpC points to the importance of ionic interactions in oligomerizationand activity

      BIOCHEMICAL JOURNAL
    32. Barrow, WW
      Treatment of mycobacterial infections

      REVUE SCIENTIFIQUE ET TECHNIQUE DE L OFFICE INTERNATIONAL DES EPIZOOTIES
    33. LoVecchio, F; Curry, SC; Graeme, KA; Wallace, KL; Suchard, J
      Intravenous pyridoxine-induced metabolic acidosis

      ANNALS OF EMERGENCY MEDICINE
    34. Powers, L; Hillar, A; Loewen, PC
      Active site structure of the catalase-peroxidases from Mycobacterium tuberculosis and Escherichia coli by extended X-ray absorption fine structure analysis

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    35. Vidrio, H; Fernandez, G
      Influence of endothelium in dose-dependent inhibition and potentiation by isoniazid of isosorbide dinitrate relaxation of rat aorta

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    36. Rebollo, S; Sanchez, P; Vega, JM; Sedano, E; Sanchis, ME; Asensio, T; Callejo, A
      Hypersensitivity syndrome from isoniazid with positive patch test

      CONTACT DERMATITIS
    37. Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV
      Strategies to decrease tuberculosis in US homeless populations - A computer simulation model

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    38. Iseman, M
      A 52-year-old man with a positive PPD

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    39. Campbell, JW; Cronan, JE
      Bacterial fatty acid biosynthesis: Targets for antibacterial drug discovery

      ANNUAL REVIEW OF MICROBIOLOGY
    40. Jenkins, PA; Banks, J; Campbell, IA; Prescott, RJ; Smith, AP
      First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol

      THORAX
    41. Li, BX; Zhang, ZJ; Liu, W
      Flow-injection system for automated dissolution testing of isoniazid tablets with chemiluminescence detection

      TALANTA
    42. Song, ZH; Lu, JH; Zhao, TZ
      Chemiluminescence sensor for isoniazid with controlled-reagent-release technology

      TALANTA
    43. Djibo, A; Lawan, A
      Behavioural disorders during treatment with isoniazid.

      BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
    44. Sassetti, CM; Boyd, DH; Rubin, EJ
      Comprehensive identification of conditionally essential genes in mycobacteria

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    45. Rodriguez, FG; Bermudez, JAB; Egido, AG
      Clinical management of latent tuberculosis

      MEDICINA CLINICA
    46. Luna, JAC
      Is chemoprophylaxis a good strategy for tuberculosis control?

      MEDICINA CLINICA
    47. Kang, TJ; You, JC; Chae, GT
      Identification of catalase-like activity from Mycobacterium leprae and therelationship between catalase and isonicotinic acid hydrazide (INH)

      JOURNAL OF MEDICAL MICROBIOLOGY
    48. Milano, A; Forti, F; Sala, C; Riccardi, G; Ghisotti, D
      Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis

      JOURNAL OF BACTERIOLOGY
    49. Raman, S; Song, TS; Puyang, XL; Bardarov, S; Jacobs, WR; Husson, RN
      The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis

      JOURNAL OF BACTERIOLOGY
    50. Master, S; Zahrt, TC; Song, J; Deretic, V
      Mapping of Mycobacterium tuberculosis katG promoters and their differential expression in infected macrophages

      JOURNAL OF BACTERIOLOGY
    51. Gupta, KC; Kumar, MNVR
      Studies on semi-interpenetrating polymer network beads of chitosan-poly(ethylene glycol) for the controlled release of drugs

      JOURNAL OF APPLIED POLYMER SCIENCE
    52. Florczyk, MA; McCue, LA; Stack, RF; Hauer, CR; McDonough, KA
      Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins

      INFECTION AND IMMUNITY
    53. Springer, B; Master, S; Sander, P; Zahrt, T; McFalone, M; Song, J; Papavinasasundaram, KG; Colston, MJ; Boettger, E; Deretic, V
      Silencing of oxidative stress response in Mycobacterium tuberculosis: Expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation

      INFECTION AND IMMUNITY
    54. Escalante, P; Graviss, EA; Griffith, DE; Musser, JM; Awe, RJ
      Treatment of isoniazid-resistant tuberculosis in southeastern Texas

      CHEST
    55. Bock, NN; Rogers, T; Tapia, JR; Herron, GD; DeVoe, B; Geiter, LJ
      Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates

      CHEST
    56. Dosso, M; Ouattara, L; Cherif, AM; Bouzid, SA; Haller, L; Fernex, M
      Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosis

      CHEMOTHERAPY
    57. Somogyi, L
      Transformation of isatin 3-acylhydrazones under acetylating conditions: Synthesis and structure elucidation of 1,5 '-disubstituted 3 '-acetylspiro[oxindole-3,2 '-[1,3,4]oxadiazolines]

      BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN
    58. Guardiola-Diaz, HM; Foster, LA; Mushrush, D; Vaz, ADN
      Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis

      BIOCHEMICAL PHARMACOLOGY
    59. Huang, YM; Zhang, ZJ
      Flow injection chemiluminescent analysis of isoniazid by direct hexacyanoferrate(III) oxidation

      ANALYTICAL LETTERS
    60. Lomillo, MAA; Renedo, OD; Martinez, MJA
      Resolution of ternary mixtures of rifampicin, isoniazid and pyrazinamide by differential pulse polarography and partial least squares method

      ANALYTICA CHIMICA ACTA
    61. Zhang, SC; Li, H
      Flow-injection chemiluminescence sensor for the determination of isoniazid

      ANALYTICA CHIMICA ACTA
    62. Espinosa-Mansilla, A; Valenzuela, MIA; de la Pena, AM; Salinas, F; Canada, FC
      Comparative study of partial least squares and a modification of hybrid linear analysis calibration in the simultaneous spectrophotometric determination of rifampicin, pyrazinamide and isoniazid

      ANALYTICA CHIMICA ACTA
    63. Echevarria, GR; Basagoitia, A; Santos, JG; Blanco, FG
      Determination of the rates of formation and hydrolysis of the Schiff basesformed by pyridoxal 5 '-phosphate and hydrazinic compounds

      JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL
    64. Bjorkman, J; Andersson, DI
      The cost of antibiotic resistance from a bacterial perspective

      DRUG RESISTANCE UPDATES
    65. Marrakchi, H; Laneelle, G; Quemard, A
      InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II

      MICROBIOLOGY-UK
    66. Slayden, RA; Barry, CE
      The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis

      MICROBES AND INFECTION
    67. Marks, GB; Bai, U; Simpson, SE; Sullivan, EA; Stewart, GJ
      Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia - Reappraising the estimates of risk

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    68. Cohn, DL; O'Brien, RJ; Geiter, LJ; Gordin, FM; Hershfield, E; Horsburgh, CR; Jereb, JA; Jordan, TJ; Kaplan, JE; Nolan, CM; Starke, JR; Taylor, Z; Villarino, ME; Binkin, NJ; Bock, NN; Castro, KG; Chaisson, RE; Comstock, RE; Dworkin, MS; El-Sadr, W; Fujiwara, PI; Glassroth, JC; Godfrey-Faussett, P; Goldberger, MJ; Hadler, JL; Hopewell, PC; Iseman, MD; Jacobs, RF; Land, MA; Lobato, MN; Menzies, RI; Migliori, GB; Miller, BI; Mwinga, A; Nardell, EA; Neaton, J; Qualls, NL; Reichman, LB; Rose, DN; Salpeter, SR; Sawert, H; Simone, PM; Snider, DE; Tsevat, J; Vernon, AA; Whalen, CC; Wilcosky, TC
      Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    69. Schwartzman, K; Menzies, D
      Tuberculosis screening of immigrants to low-prevalence countries - A cost-effectiveness analysis

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    70. Gilroy, SA; Rogers, MAM; Blair, DC
      Treatment of latent tuberculosis infection in patients aged >= 35 years

      CLINICAL INFECTIOUS DISEASES
    71. Cohn, DL
      Treatment of latent tuberculosis infection: Renewed opportunity for tuberculosis control

      CLINICAL INFECTIOUS DISEASES
    72. Macintyre, CR; Plant, AJ; Hendrie, D
      The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis

      HEALTH ECONOMICS
    73. Mitchison, DA
      Role of individual drugs in the chemotherapy of tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    74. Geerligs, WA; van Altena, R; de Lange, WCM; van Soolingen, D; van der Werf, TS
      Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    75. Lee, H; Cho, SN; Bang, HE; Lee, JH; Bai, GH; Kim, SJ; Kim, JD
      Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    76. Ohno, M; Yamaguchi, I; Yamamoto, I; Fukuda, T; Yokota, S; Maekura, R; Ito, M; Yamamoto, Y; Ogura, T; Maeda, K; Komuta, K; Igarashi, T; Azuma, J
      Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid andrifampicin-induced hepatotoxicity

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    77. Tam, CM; Chan, SL; Kam, KM; Sim, E; Staples, D; Sole, KM; Al-Ghusein, H; Mitchison, DA
      Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    78. Riska, PF; Jacobs, WR; Alland, D
      Molecular determinants of drug resistance in tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    79. Taylor, Z
      The cost-effectiveness of screening for latent tuberculosis infection

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    80. Schaaf, HS; Gie, RP; Beyers, N; Sirgel, FA; de Klerk, PJ; Donald, PR
      Primary drug-resistant tuberculosis in children

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    81. Attri, S; Rana, SV; Vaiphei, K; Sodhi, CP; Katyal, R; Goel, RC; Nain, CK; Singh, K
      Isoniazid- and rifampicin-induced oxidative hepatic injury - protection byN-acetylcysteine

      HUMAN & EXPERIMENTAL TOXICOLOGY
    82. Loprasert, S; Fuangthong, M; Whangsuk, W; Atichartpongkul, S; Mongkolsuk, S
      Molecular and physiological analysis of an OxyR-regulated ahpC promoter inXanthomonas campestris pv. phaseoli

      MOLECULAR MICROBIOLOGY
    83. Triccas, JA; Gicquel, B
      Life on the inside: Probing Mycobacterium tuberculosis gene expression during infection

      IMMUNOLOGY AND CELL BIOLOGY
    84. Naidu, PS; Kulkarni, SK
      Differential role of dopamine D-1 and D-2 receptors in isoniazid-induced vacuous chewing movements

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    85. Naba, I; Yoshikawa, H; Sakoda, S; Itabe, H; Suzuki, H; Kodama, T; Yanagihara, T
      Successful generation of peripheral neuropathy with onion-bulb formation in the macrophage scavenger receptor classA knockout mouse treated with isoniazid

      NEUROSCIENCE LETTERS
    86. Al Khalifa, M; Elfving, P; Mansson, W; Colleen, S; Hellsten, S; Duchek, M; Nyberg, G; Callaghan, P; Rademark, C; Eriksson, R; Olsson, R; Hagberg, G; Nelson, CE
      The effect of isoniazid on BCG-induced toxicity in patients with superficial bladder cancer

      EUROPEAN UROLOGY
    87. Rischmann, P; Desgrandchamps, F; Malavaud, B; Chopin, DK
      BCG intravesical instillations: Recommendations for side-effects management

      EUROPEAN UROLOGY
    88. Waiser, J; Schotschel, R; Budde, K; Neumayer, HH
      Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation

      AMERICAN JOURNAL OF KIDNEY DISEASES
    89. Corbett, EL; Churchyard, GJ; Clayton, TC; Williams, BG; Mulder, D; Hayes, RJ; De Cock, KM
      HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners

      AIDS
    90. Girardi, E; Raviglione, MC; Antonucci, G; Godfrey-Faussett, P; Ippolito, G
      Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis

      AIDS
    91. Russell, LB; Sisk, JE
      Modeling age differences in cost-effectiveness analysis - A review of the literature

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    92. Churchyard, GJ; Grant, AD
      HIV infection, tuberculosis and non-tuberculous mycobacteria

      SOUTH AFRICAN MEDICAL JOURNAL
    93. MacIntyre, CR; Ansari, MZ; Carnie, J; Hart, WG
      No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in southeast Asian refugees and migrants: Completion and compliance are major determinants of effectiveness

      PREVENTIVE MEDICINE
    94. Martinjak-Dvorsek, I; Gorjup, V; Horvat, M; Noc, M
      Acute isoniazid neurotoxicity during preventive therapy

      CRITICAL CARE MEDICINE
    95. Piatek, AS; Telenti, A; Murray, MR; El-Hajj, H; Jacobs, WR; Kramer, FR; Alland, D
      Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: Implications for rapid susceptibility testing

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    96. Meyers, BR; Papanicolaou, GA; Sheiner, P; Emre, S; Miller, C
      Tuberculosis in orthotopic liver transplant patients: Increased toxicity of recommended agents; Cure of disseminated infection with nonconventional regimens

      TRANSPLANTATION
    97. Cengiz, K
      Should tuberculosis prophylaxis be given for the chronically dialyzed patients?

      NEPHRON
    98. Alfaro, EM; Cuadra, F; Solera, J; Macia, MA; Geijo, P; Martinez, PAS; Zapata, MR; Largo, J; Sepulveda, MA; Rosa, C; Sanchez, L; Espinosa, A; Mateos, F; Blanch, JJ
      Assessment of two chemoprophylaxis regimens for tuberculosis in HIV-infected patients

      MEDICINA CLINICA
    99. Ruiz-Navarro, D; Alvarez, H; Casbas, M; Perez, G; Gonzalez, C; Rodriguez, P; Mejias, A; Carrillo, C; Murillo, C; Garcia, D; Diz, G; Avila, G; De Valdivieso, L; Lucena, M; Sanchez, N; Blandon, P; Rodriguez, P; Garcia, Q; Ferron, R; Romero, S; Luna, V; Alonso, V; Bueno, A; Bernal, A; Carrion, A; Oliva, A; Rodriguez, A; Garcia, A; Irurzun, B; Sillero, B; Rodriguez, B; Manzanares, B; Barrientos, B; Dacal, B; Alvarez, B; Gomez-Moran, C; Cura, BJC; Gracia, C; Gil, C; Perez, C; Sanchez, C; Sanchez, C; Baelo, C; Lopez-Areal, D; Munoz, D; Perez, D; Avedillo, C; Castellano, D; Bouza, E; Martinez, E; Sierra, F; Monilor, F; Olivares, G; Marin, G; Calabuig, G; Fulgueiras, G; Gonzalez, G; Hidalgo, G; Fernandez, GA; Martinez, G; Garcia, G; Zabala, G; Anes, G; Castro, G; Garcia, G; Luque, G; Moran, G; Torga, G; Perez, G; Galvez, H; Hernandez, H; Perez, H; Cifredo, H; Garcia, I; del Vallado, JL; Rodriguez, J; Aracil, J; Gomez, J; Claret, L; Jurado, L; Barrero, L; Rico, L; de Valdivielso, L; Hidalgo, LT; Cruz, L; Rodriguez, M; Ruiz, M; Lirola, M; Memendez, M; Verges, M; Martinez, M; Suarez-Varela, M; Arrastio, M; Lucena, M; Cobos, P; Parra, P; Pascual, P; Berenguer, P; de Torres, P; Julia, P; Zubizarreta, O; Gutierrez, P; Sanchez, P; Fatsini, R; Iglesias, R; Sena, R; Palacios, R; Cosin, R; Leon, R; Solano, S; Gascon, F; Guijarro, S; Paya, S; Rodilla, S; Perez, S; Catorre, U; Rodriguez, V; Castro, V; Hernando, V; Alenda, V; Garcia, Z; Santos, A; Garcia, A; Aragones, A; Ruiz, A; Rueda, C; Barrios, M; Pastor, P; Duran, R; Pena, S; Romero, Z; Perez, G
      Incidence of tuberculosis in Spain: results from the Multicenter Project for Tuberculosis Research (MPTR)

      MEDICINA CLINICA
    100. Lewis, JH
      Drug-induced liver disease

      MEDICAL CLINICS OF NORTH AMERICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 09:36:54